Skip to main content

AI Software to Detect Large Vessel Occlusion Cuts Workflow Time

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Sept. 21, 2023 -- Artificial intelligence (AI)-detected large vessel occlusion (LVO) ischemic stroke coupled with secure mobile phone application-based communication improves in-hospital acute ischemic stroke workflows, according to a study published online Sept. 18 in JAMA Neurology.

Juan Carlos Martinez-Gutierrez, M.D., from UT Health in Houston, and colleagues assessed whether automated computed tomography (CT) angiogram interpretation coupled with secure group messaging can improve in-hospital endovascular stroke therapy (EVT) workflows. The analysis included 243 participants with LVO stroke who presented through the emergency department and were treated with EVT at four comprehensive stroke centers.

The researchers found that implementation of the AI algorithm was associated with a reduction in door-to-groin time by 11.2 minutes, while time from CT scan initiation to EVT start declined by 9.8 minutes. However, there were no differences seen in intravenous tissue plasminogen activator treatment times or hospital length of stay. When adjusting for age, National Institutes of Health Stroke scale score, and the Alberta Stroke Program Early CT Score, there was no difference observed in the likelihood of functional independence as measured by the modified Rankin Scale score (odds ratio, 1.3; 95 percent confidence interval, 0.42 to 4.0).

"In a cohort as heterogeneous as this one, in which nearly all patients with EVT presenting through the emergency department were included, it is unlikely that our sample size would provide sufficient power to detect a difference in clinical outcomes with an 11-minute acceleration in care," the authors write.

One author disclosed ties to the medical technology industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.